From pharmaceutical drug discovery to agricultural genomics — we decode complex data into clear, actionable insights.
Get in Touch
The GWAS-based target identification service analyzes large-scale genotype–phenotype cohorts to detect robust disease-associated loci. It delivers reproducible candidate genes and regions that can be prioritized for downstream functional validation. This provides a structured input into pre-clinical target selection and portfolio decisions.
The multi-omics biomarker discovery service integrates genomics, transcriptomics, proteomics, metabolomics and epigenetics using systems biology workflows. It focuses on identifying robust, clinically meaningful markers for diagnostic, prognostic or treatment response applications. The service also supports design of technical and biological validation strategies.
Prognostic biomarker panels estimate disease outcome, progression or relapse risk using validated molecular signatures. The service delivers statistically calibrated scores and risk categories that can be integrated into clinical decision support or diagnostic products. It emphasizes robustness, interpretability and regulatory-ready documentation.
Therapeutic response predictor services build gene expression-based classifiers, optionally combined with other molecular layers, to anticipate which patients will benefit from a given treatment. Outputs include validated signatures and cut-offs that can be used for stratification in clinical practice or trials. This improves response rates and reduces unnecessary exposure to ineffective therapies.
Pharmacogenomic biomarker services profile variants in drug-metabolizing enzymes and transporters to inform dosing and safety. The focus is on CYP450 genes (CYP2D6, CYP2C19…), key transporters such as ABCB1, and clinically actionable alleles. Results can be translated into dosing guidelines and risk categories aligned with international recommendations.
TMB analysis quantifies the somatic mutation load in tumor–normal pairs, usually expressed as mutations per megabase. The service applies harmonized pipelines that account for panel size and coverage to produce comparable TMB values. These outputs are suitable for informing immunotherapy decisions and for inclusion in clinical reports.
MSI detection services identify mismatch repair deficiency through instability patterns at microsatellite loci. Using NGS- or PCR-based assays, tumors are classified into MSI-H, MSI-L or MSS categories. These results support eligibility assessment for specific immunotherapies and provide prognostic insights.
Genomic and sequence analysis provides the core bioinformatics workflows required to turn raw sequencing data into interpretable results. It covers QC, alignment, variant calling and annotation across human, microbial and agricultural genomes, among others. The service is adaptable to custom reference builds, panels and study designs.
Whole genome sequencing services deliver from low- to high-coverage sequencing and analysis of entire genomes. Typical applications include rare disease diagnostics, population genomics and complex trait studies. Outputs cover single nucleotide variants, indels and structural variants, e.g. copy number changes.
Whole exome sequencing targets coding regions, providing a cost-efficient alternative to WGS for many clinical and research applications. It is particularly suited to Mendelian disorders and cancer gene panels. The service includes coverage assessment, variant calling and prioritization of clinically relevant findings.
Long-read sequencing with PacBio HiFi (>99.9% accuracy, 10–20 kb reads) and Oxford Nanopore technologies enables resolution of complex genomic structures, repeats and structural variants. It is ideal for de novo genome assembly, haplotype phasing and difficult genomic regions. The service provides end-to-end processing from raw signals to annotated assemblies and variant catalogues.
Functional genomics and CRISPR screening services use targeted perturbations to map gene function and genetic interactions. They support identification of essential genes, drug targets and synthetic lethal pairs. The offering covers library design, experimental design support and high-throughput data analysis, including AI-guided gene editing design with CRISPR-GPT achieving 80% editing efficiency on first attempt.
Single-cell RNA-seq services profile transcriptomes at single-cell resolution to dissect heterogeneous cell populations. Deliverables include clustering, cell type annotation and trajectory or state analysis. Typical use cases are tumour microenvironment characterization, immune profiling and developmental studies.
Metagenomic and pathogen detection services use 16S/18S rRNA and shotgun sequencing to characterize microbial communities and identify specific pathogens. They support environmental, clinical and food safety applications. Outputs include taxonomic and functional profiles, antimicrobial resistance gene detection and genome assemblies for key taxa.
Multi-omics integration services jointly analyze genomic, epigenomic, transcriptomic, proteomic, lipidomic and microbiome data. The aim is to build holistic models of biological systems and generate testable hypotheses. Outputs include network models, integrated biomarker candidates and predictive models for defined endpoints.
High-performance computing cluster management ensures that genomics and bioinformatics workflows run reliably at scale. The service covers resource management, job scheduling, monitoring and security. It can be tailored to on-premise, cloud or hybrid infrastructures.
Open-source tool and pipeline development focuses on building reproducible and transparent bioinformatics workflows. The service includes software architecture design, version control and comprehensive documentation. Deliverables are maintainable, community-ready code bases and pipelines.
Genome annotation and comparative genomics services perform gene prediction, functional annotation and cross-species comparison. They support orthology detection, synteny analysis and phylogenetic reconstruction. Typical applications include evolutionary studies, functional inference and agricultural trait analysis.
Training and education services provide structured bioinformatics curricula, workshops and online courses. They aim to enable partner teams to operate and extend developed pipelines and tools independently. Content is adapted to the audience's background and project-specific needs.
Epigenetic analysis services profile chromatin accessibility and DNA methylation patterns using ATAC-seq and bisulfite sequencing. They enable mapping of regulatory elements and epigenetic state changes. Use cases include oncology, immunology and developmental biology studies.
Liquid biopsy and circulating biomarker services analyze circulating tumor DNA, cell-free DNA, CTCs (circulating tumor cells), extracellular vesicles and ddPCR-based targets. They support early cancer detection, relapse monitoring and minimal residual disease assessment. Workflows are designed for integration into clinical trials and routine diagnostic settings. Multi-modal cfDNA analysis achieves 94.9% sensitivity and 88.8% specificity.
Rare disease diagnostics leverage WES/WGS data to identify causative variants in Mendelian disorders. The workflow includes variant prioritization, filtering and clinical interpretation using frameworks such as ClinVar, OMIM and VEP. Phenotypic and family information are systematically integrated to increase diagnostic yield.
Oncology diagnostics services generate comprehensive genomic and transcriptomic profiles from tumor samples. They cover somatic variants, structural alterations, CNAs, TMB, MSI, HRD, gene fusions and immune signatures. Deliverables are clinically interpretable reports suitable for tumor boards and therapy decision-making.
Infectious disease diagnostics use NGS to identify pathogens, quantify viral load and profile antimicrobial resistance. Applications include acute infections, sepsis and outbreak surveillance. The service also supports lineage and variant tracking and antibiotic susceptibility inference.
Clinical pharmacogenomics services support drug safety and efficacy decisions by genotyping key pharmacogenes such as CYP450s, TPMT, NUDT15 and HLA alleles. Outputs are guideline-aligned dosing and risk recommendations. Workflows are designed to integrate into electronic health records and prescribing systems.
Upgrade your diagnostic results with our service: we reanalyze your existing genetic data (NGS, WES/WGS) using the latest bioinformatic pipelines, reference databases, and variant classification guidelines to maximize diagnostic yield and clinical relevance.
Epigenetic analysis services profile chromatin accessibility and DNA methylation patterns using ATAC-seq and bisulfite sequencing. They enable mapping of regulatory elements and epigenetic state changes. Use cases include oncology, immunology and developmental biology studies.
Agricultural genomics and crop improvement services provide pedigree analysis, genome-wide association studies and QTL mapping, among others. We also provide assistance in the development or application of genomic selection or marker-assisted selection programmes. The aim is to accelerate development of high-yielding, stress-tolerant and disease-resistant varieties. The workflows integrate seamlessly with breeding programs at seed companies and research institutes.
Animal breeding genomics services apply genomic selection and marker-based decision support to improve production, health and welfare traits. They provide population-level genetic evaluation and breeding value estimation. Offerings can be tailored to breeding organizations and livestock companies.
Precision nutrition and nutrigenomics services analyze interactions between genetic background, diet and metabolic responses. Use cases include personalized diet recommendations, clinical studies and functional food development. The service integrates multiple omics and clinical data types.
Microbiome and personalized medicine services use 16S/shotgun metagenomics to characterize composition and function of gut and other microbiomes. Results can be integrated with clinical and multi-omics data. Typical applications include chronic disease research, metabolic syndrome and response to immunotherapy.
Whether you want advice about the most suitable analyses to further your research or a quote for a specific service, feel free to contact us and we will get back to you within 48 hours.
